IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Almac Expects High Sales Growth, Especially in U.S.

9:25 AM MST | February 25, 2008 | Alex Scott

Almac (Craigavon, U.K.), a privately owned pharmaceutical services group, says it is on track to grow sales significantly during the next few years and in the U.S. in particular. Group sales increased 16% in 2007, to £150.1 million ($293 million), and are expected to rise a further 20% this year, the company said at a press briefing, held recently at its Craigavon headquarters. Almac says its long-term goal is to expand its U.S. market presence. The firm’s largest single capital investment this year is a proposed $100-million project to build a U.S...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.



Not an IHS Chemical Week member yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine in print or digital format
  • Critical daily news and analysis on chemweek.com
  • Free mobile edition 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now

100% Satisfaction Guarantee
If at any time you are not completely satisfied with IHS Chemical Week, simply notify us and we'll refund the balance of your paid subscription - no problem.

Learn more about group subscriptions and site licenses.

 














 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2015 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa